Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Endocrine and other factor-regulated calcium reabsorption (mmu04961)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
AK078587
KLA  ATP  ATP+KLA
 AK078587 11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] KLA 1.37 1.28 1.13 1.06 1.15 1.31 1.22
ATP 1.04 1.08 1.21 1.22 1.27 1.12 1.14
KLA/ATP 1.48 1.66 1.97 1.26 1.17 1.03 1.28
Ap2a1
KLA  ATP  ATP+KLA
 NM_007458 adaptor protein complex AP-2, alpha 1 subunit (Ap2a1), transcript variant 1, mRNA [NM_007458] KLA .92 1.14 1.16 .91 1.06 1.21 1.21
ATP 1.24 1.66 .77 1.57 1.08 .88 1.32
KLA/ATP 1.36 1.16 .56 1.31 .71 1.02 1.46
Ap2a2
KLA  ATP  ATP+KLA
 NM_007459 adaptor protein complex AP-2, alpha 2 subunit (Ap2a2), mRNA [NM_007459] KLA .89 .90 .92 .77 .91 .83 .86
ATP 1.14 1.15 .86 1.08 .78 .53 1.29
KLA/ATP .94 .98 .67 .85 .54 .51 .99
Ap2b1
KLA  ATP  ATP+KLA
 AK030505 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330422K01 product:adaptor-related protein complex 2, beta 1 subunit, full insert sequence. [AK030505] KLA 1.84 1.44 1.49 1.36 1.58 1.21 1.05
ATP .78 .61 .53 .74 1.81 1.99 1.09
KLA/ATP 1.32 1.13 .92 1.01 2.31 1.59 1.18
Ap2b1
KLA  ATP  ATP+KLA
 NM_001035854 adaptor-related protein complex 2, beta 1 subunit (Ap2b1), transcript variant 1, mRNA [NM_001035854] KLA 2.27 2.24 2.05 2.41 2.07 2.26 1.93
ATP .91 .89 1.02 1.00 .92 2.14 3.06
KLA/ATP 1.94 2.11 2.16 1.95 1.67 1.61 4.01
Ap2m1
KLA  ATP  ATP+KLA
 AK141862 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130035H06 product:adaptor protein complex AP-2, mu1, full insert sequence [AK141862] KLA .80 .69 .92 .86 .81 .97 .67
ATP 1.09 .73 .91 .85 2.29 1.04 .60
KLA/ATP .87 .60 .76 .96 2.66 .86 .59
Ap2m1
KLA  ATP  ATP+KLA
 NM_009679 adaptor protein complex AP-2, mu1 (Ap2m1), mRNA [NM_009679] KLA .81 .86 .90 .77 .88 .92 1.12
ATP 1.06 1.28 .69 .98 .77 .64 1.24
KLA/ATP 1.00 1.03 .51 .87 .54 .67 1.01
Ap2s1
KLA  ATP  ATP+KLA
 NM_198613 adaptor-related protein complex 2, sigma 1 subunit (Ap2s1), mRNA [NM_198613] KLA .91 .94 .95 .87 .96 .98 .82
ATP 1.01 1.09 .66 .94 .67 .64 1.39
KLA/ATP 1.05 1.02 .67 .97 .69 .82 1.19
Atp1a1
KLA  ATP  ATP+KLA
 NM_144900 ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] KLA .78 .94 .68 .81 .62 .55 .75
ATP 1.02 1.05 .86 .85 1.77 2.54 1.11
KLA/ATP .83 .99 .80 .75 .91 1.15 .68
Atp1a2
KLA  ATP  ATP+KLA
 NM_178405 ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] KLA 1.03 .98 1.03 1.05 1.03 .98 1.02
ATP 1.03 .98 1.06 1.05 1.05 .93 1.07
KLA/ATP 1.04 1.05 1.02 1.02 .98 .92 1.02
Atp1a3
KLA  ATP  ATP+KLA
 AK053751 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] KLA .88 .87 .74 .80 .84 .88 .93
ATP .96 .83 .80 .88 .94 .89 1.15
KLA/ATP .89 .86 .79 .90 .93 .84 .92
Atp1a3
KLA  ATP  ATP+KLA
 NM_144921 ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] KLA .99 .87 .96 .86 .81 .61 .52
ATP 1.22 1.21 1.16 1.38 1.27 .92 1.30
KLA/ATP .96 1.10 1.17 1.42 1.11 .91 .93
Atp1b1
KLA  ATP  ATP+KLA
 NM_009721 ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] KLA .97 1.02 1.08 .98 .95 1.01 1.09
ATP 1.07 1.05 1.09 1.09 1.02 1.17 1.11
KLA/ATP .99 .99 .93 1.02 1.00 1.07 1.04
Atp1b2
KLA  ATP  ATP+KLA
 NM_013415 ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] KLA 1.18 1.09 1.11 1.12 1.16 1.12 1.15
ATP .95 .98 .99 1.26 1.06 1.10 1.07
KLA/ATP 1.15 1.16 1.09 1.19 1.27 1.13 1.02
Atp1b3
KLA  ATP  ATP+KLA
 NM_007502 ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] KLA 1.86 2.10 2.25 2.21 2.68 3.26 3.45
ATP 1.08 1.09 .93 1.13 1.55 2.14 2.38
KLA/ATP 1.95 2.10 1.84 2.34 2.20 2.96 4.69
Atp1b4
KLA  ATP  ATP+KLA
 NM_133690 ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] KLA .99 1.02 1.03 1.01 .95 .90 1.00
ATP 1.00 1.05 1.04 .98 1.07 .98 .97
KLA/ATP 1.00 1.05 1.03 1.04 .96 .97 1.01
Atp2b1
KLA  ATP  ATP+KLA
 AK053569 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111D10 product:unclassifiable, full insert sequence. [AK053569] KLA 1.18 1.02 .86 .87 .88 .99 .97
ATP 1.38 1.60 8.03 2.45 1.66 1.16 .94
KLA/ATP 1.32 1.41 6.67 1.98 1.15 1.08 .96
Atp2b1
KLA  ATP  ATP+KLA
 AK161995 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720440F18 product:Plasma membrane calcium pump isoform 1b (Fragment) homolog [Canis familiaris], full insert sequence. [AK16199 KLA 1.64 1.50 1.23 1.02 .71 .75 .92
ATP 1.04 1.12 1.69 1.64 1.34 1.03 .66
KLA/ATP 1.69 1.58 2.20 1.99 1.03 .67 .57
Atp2b1
KLA  ATP  ATP+KLA
 NM_026482 ATPase, Ca++ transporting, plasma membrane 1 (Atp2b1), mRNA [NM_026482] KLA 1.91 1.76 1.64 1.21 .84 .79 1.07
ATP 1.00 1.01 1.43 2.32 2.28 1.71 1.06
KLA/ATP 1.86 1.85 2.23 2.48 1.71 1.05 1.04
Bdkrb2
KLA  ATP  ATP+KLA
 NM_009747 bradykinin receptor, beta 2 (Bdkrb2), mRNA [NM_009747] KLA .97 .96 1.01 1.09 1.01 1.00 1.08
ATP 1.07 .98 1.04 1.01 1.05 1.00 1.08
KLA/ATP 1.02 1.05 1.04 1.01 1.03 1.04 .98
Calb1
KLA  ATP  ATP+KLA
 NM_009788 calbindin-28K (Calb1), mRNA [NM_009788] KLA 1.01 .99 1.00 .99 1.00 1.02 .99
ATP .99 1.00 1.01 1.03 .99 1.01 1.03
KLA/ATP 1.01 1.00 1.04 1.00 1.00 1.00 1.02
Clta
KLA  ATP  ATP+KLA
 AK035903 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630016K07 product:unclassifiable, full insert sequence [AK035903] KLA 1.01 1.00 .97 1.02 1.01 1.12 1.09
ATP 1.04 .98 .91 1.05 1.02 1.01 .95
KLA/ATP 1.00 .99 .93 1.07 1.09 .98 .99
Clta
KLA  ATP  ATP+KLA
 NM_016760 clathrin, light polypeptide (Lca) (Clta), transcript variant 3, mRNA [NM_016760] KLA .68 .70 .75 .68 .70 .77 .55
ATP 1.06 1.05 .93 .97 .81 .60 .75
KLA/ATP .75 .76 .68 .71 .69 .64 .42
Cltb
KLA  ATP  ATP+KLA
 NM_028870 clathrin, light polypeptide (Lcb) (Cltb), mRNA [NM_028870] KLA .91 1.01 .97 .78 .71 .52 .73
ATP 1.15 1.32 1.07 1.72 1.96 1.94 1.31
KLA/ATP 1.07 1.17 .76 1.17 1.18 2.12 1.06
Cltc
KLA  ATP  ATP+KLA
 AK039453 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330045B10 product:CLATHRIN HEAVY CHAIN 1 (CLH-17) homolog [Homo sapiens], full insert sequence. [AK039453] KLA 1.07 1.00 1.01 1.00 1.03 1.06 1.02
ATP 1.00 .99 1.02 .97 1.00 1.02 1.00
KLA/ATP 1.01 1.01 1.02 .98 1.04 .98 .99
Cltc
KLA  ATP  ATP+KLA
 NM_001003908 clathrin, heavy polypeptide (Hc) (Cltc), mRNA [NM_001003908] KLA .94 1.00 .98 .89 1.18 1.02 .93
ATP 1.21 1.42 .72 .89 .93 .96 .75
KLA/ATP 1.12 1.21 .48 .72 .57 .87 .81
Dnm1
KLA  ATP  ATP+KLA
 NM_010065 dynamin 1 (Dnm1), mRNA [NM_010065] KLA .96 .92 .87 .88 .85 .79 1.16
ATP 1.05 1.08 .96 1.04 .93 .80 1.59
KLA/ATP .99 1.00 .82 .93 .79 .79 1.24
Dnm2
KLA  ATP  ATP+KLA
 NM_001039520 dynamin 2 (Dnm2), mRNA [NM_001039520] KLA 1.00 1.03 1.14 1.01 1.29 1.47 1.30
ATP 1.11 1.31 .93 1.41 1.04 .90 1.53
KLA/ATP 1.26 1.23 .87 1.41 .86 .98 1.86
Dnm3
KLA  ATP  ATP+KLA
 NM_001038619 dynamin 3 (Dnm3), mRNA [NM_001038619] KLA 1.00 1.01 1.02 1.02 1.03 .96 1.04
ATP 1.05 1.01 .99 .96 1.03 .97 .88
KLA/ATP 1.03 1.05 1.03 .99 .98 1.02 1.03
Esr1
KLA  ATP  ATP+KLA
 NM_007956 estrogen receptor 1 (alpha) (Esr1), mRNA [NM_007956] KLA 1.06 1.05 1.11 1.36 1.33 1.02 .90
ATP 1.05 .92 1.02 .94 1.02 .83 .67
KLA/ATP 1.02 .98 1.09 1.08 1.32 1.07 .71
Fxyd2
KLA  ATP  ATP+KLA
 NM_052823 FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] KLA 1.07 .97 1.09 .98 1.02 .96 .83
ATP 1.07 1.22 1.00 1.14 1.00 1.22 4.11
KLA/ATP 1.06 1.11 .96 1.13 .98 1.01 1.02
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Kl
KLA  ATP  ATP+KLA
 AB010088 mRNA for secreted isoform of Klotho protein, complete cds [AB010088] KLA 1.02 1.00 1.01 .97 1.02 1.04 1.01
ATP 1.03 1.03 .99 1.00 .99 .97 1.01
KLA/ATP 1.03 .93 .98 .87 .96 .92 .93
Kl
KLA  ATP  ATP+KLA
 NM_013823 klotho (Kl), mRNA [NM_013823] KLA .97 .96 1.08 .95 1.01 .95 1.05
ATP .96 1.07 1.02 1.06 1.05 1.00 1.02
KLA/ATP .95 1.02 1.04 1.04 1.11 1.01 .96
Klk1
KLA  ATP  ATP+KLA
 NM_010639 kallikrein 1 (Klk1), mRNA [NM_010639] KLA 1.01 .98 1.26 1.09 1.09 .97 1.06
ATP 1.08 1.03 1.10 1.00 1.01 .90 1.05
KLA/ATP .99 1.04 1.08 1.06 1.02 1.05 1.04
Klk1b1
KLA  ATP  ATP+KLA
 NM_010645 kallikrein 1-related peptidase b1 (Klk1b1), mRNA [NM_010645] KLA .89 1.02 .98 1.03 1.03 .95 1.11
ATP 1.05 1.03 1.02 1.01 1.04 .98 1.01
KLA/ATP .99 1.00 .99 .98 .97 1.06 .99
Klk1b11
KLA  ATP  ATP+KLA
 NM_010640 kallikrein 1-related peptidase b11 (Klk1b11), mRNA [NM_010640] KLA .99 .96 1.00 .99 1.00 1.00 .76
ATP 1.04 1.05 1.07 1.06 1.02 1.17 1.50
KLA/ATP .93 .94 .98 .97 .97 1.07 1.20
Klk1b21
KLA  ATP  ATP+KLA
 NM_010642 kallikrein 1-related peptidase b21 (Klk1b21), mRNA [NM_010642] KLA 1.01 .99 .98 .94 .96 .96 1.01
ATP 1.02 .97 .98 1.00 1.03 1.02 1.04
KLA/ATP .92 .98 1.06 1.07 .93 1.02 1.04
Klk1b24
KLA  ATP  ATP+KLA
 NM_010643 kallikrein 1-related peptidase b24 (Klk1b24), mRNA [NM_010643] KLA .99 .99 1.00 .97 .92 .95 .97
ATP .94 .98 1.03 1.00 .96 1.00 .98
KLA/ATP 1.02 1.03 1.09 1.00 1.00 1.01 .92
Klk1b26
KLA  ATP  ATP+KLA
 NM_010644 kallikrein 1-related petidase b26 (Klk1b26), mRNA [NM_010644] KLA 1.01 .98 .99 .96 .96 1.01 .95
ATP .93 1.07 .99 .94 .92 1.00 1.05
KLA/ATP .93 .97 .99 .94 .99 .94 1.03
Klk1b3
KLA  ATP  ATP+KLA
 NM_008693 kallikrein 1-related peptidase b3 (Klk1b3), mRNA [NM_008693] KLA 1.13 1.16 1.13 1.19 1.20 1.24 1.24
ATP .99 1.04 1.10 1.08 1.03 1.05 1.04
KLA/ATP 1.15 1.18 1.08 1.16 1.08 1.12 1.25
Klk1b8
KLA  ATP  ATP+KLA
 NM_008457 kallikrein 1-related peptidase b8 (Klk1b8), mRNA [NM_008457] KLA 1.01 .97 1.01 1.06 1.02 1.08 1.07
ATP 1.01 1.02 1.00 .98 1.04 1.10 1.00
KLA/ATP 1.08 1.12 1.07 1.07 1.04 1.08 1.03
Klk1b9
KLA  ATP  ATP+KLA
 NM_010116 kallikrein 1-related peptidase b9 (Klk1b9), mRNA [NM_010116] KLA .98 1.06 1.08 .97 1.09 1.16 1.02
ATP 1.00 .99 .92 1.01 .98 .94 .93
KLA/ATP 1.10 1.12 1.02 1.04 .96 1.01 1.00
Mm.13573
4
KLA  ATP  ATP+KLA
 111186473 Unknown KLA .94 1.00 .98 .96 .99 1.02 .97
ATP 1.02 1.06 .96 .95 .99 .99 .99
KLA/ATP .99 1.03 .99 .97 .96 1.06 1.01
Mm.24508
4
KLA  ATP  ATP+KLA
 144227202 Unknown KLA 1.06 1.07 1.19 1.42 1.09 .83 .67
ATP .99 1.02 1.16 1.40 1.51 1.67 1.61
KLA/ATP 1.04 1.06 1.35 1.56 1.65 1.92 2.49
Mm.29002
6
KLA  ATP  ATP+KLA
 146141141 Unknown KLA .86 .76 .74 .94 .70 .57 .57
ATP 1.05 .94 1.16 1.33 2.13 2.57 1.15
KLA/ATP .74 .84 1.09 1.07 1.49 2.42 1.05
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Mm.44329
2
KLA  ATP  ATP+KLA
 195546951 Unknown KLA 1.01 1.02 1.09 1.04 1.00 1.00 .81
ATP .98 1.01 1.14 1.05 1.02 1.22 1.31
KLA/ATP 1.01 1.01 .98 1.10 1.07 1.10 1.08
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Pthr1
KLA  ATP  ATP+KLA
 NM_011199 parathyroid hormone receptor 1 (Pthr1), transcript variant 1, mRNA [NM_011199] KLA .82 .90 .89 .94 .88 .86 .93
ATP 1.08 .95 .93 .89 .83 .86 .85
KLA/ATP .95 .87 .81 .86 .91 .93 .87
Rab11a
KLA  ATP  ATP+KLA
 NM_017382 RAB11a, member RAS oncogene family (Rab11a), mRNA [NM_017382] KLA .96 .92 .94 .94 1.01 1.05 1.00
ATP 1.04 1.08 1.09 1.15 .88 .73 .87
KLA/ATP .99 .98 .96 1.03 .84 .74 .97
Slc8a1
KLA  ATP  ATP+KLA
 AF004666 sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] KLA 1.13 1.10 1.22 1.44 1.52 1.55 1.10
ATP 1.03 1.05 1.22 1.12 .65 .49 .67
KLA/ATP 1.04 1.21 1.30 1.44 .81 .63 1.01
Slc8a1
KLA  ATP  ATP+KLA
 AF108396 sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] KLA 1.07 1.18 1.30 1.22 1.31 1.39 1.21
ATP 1.03 1.02 1.10 1.07 .88 .91 1.23
KLA/ATP 1.15 1.17 1.14 1.22 .96 1.01 1.77
Slc8a1
KLA  ATP  ATP+KLA
 NM_011406 solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] KLA 1.12 1.16 1.22 1.25 1.35 1.33 1.11
ATP 1.03 1.04 1.07 1.10 .93 .90 1.19
KLA/ATP 1.13 1.24 1.19 1.16 .93 1.06 1.62
Trpv5
KLA  ATP  ATP+KLA
 NM_001007572 transient receptor potential cation channel, subfamily V, member 5 (Trpv5), mRNA [NM_001007572] KLA 1.00 .96 1.03 .99 .98 .95 .87
ATP .98 1.01 .96 1.01 1.00 1.05 1.01
KLA/ATP .99 1.08 1.08 .98 .92 .95 .95
Vdr
KLA  ATP  ATP+KLA
 NM_009504 vitamin D receptor (Vdr), mRNA [NM_009504] KLA 1.01 1.01 1.12 1.12 1.09 .96 .94
ATP .99 1.03 1.09 1.19 1.25 1.24 1.36
KLA/ATP .99 1.03 1.03 1.28 1.21 1.42 1.76